PL102193B1 - A process of producing new cyclic urethans - Google Patents

A process of producing new cyclic urethans Download PDF

Info

Publication number
PL102193B1
PL102193B1 PL1977202443A PL20244377A PL102193B1 PL 102193 B1 PL102193 B1 PL 102193B1 PL 1977202443 A PL1977202443 A PL 1977202443A PL 20244377 A PL20244377 A PL 20244377A PL 102193 B1 PL102193 B1 PL 102193B1
Authority
PL
Poland
Prior art keywords
formula
solution
reaction
mol
water
Prior art date
Application number
PL1977202443A
Other languages
English (en)
Polish (pl)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of PL102193B1 publication Critical patent/PL102193B1/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/20—Carbocyclic rings
    • C07H15/22—Cyclohexane rings, substituted by nitrogen atoms
    • C07H15/222—Cyclohexane rings substituted by at least two nitrogen atoms
    • C07H15/226—Cyclohexane rings substituted by at least two nitrogen atoms with at least two saccharide radicals directly attached to the cyclohexane rings
    • C07H15/234—Cyclohexane rings substituted by at least two nitrogen atoms with at least two saccharide radicals directly attached to the cyclohexane rings attached to non-adjacent ring carbon atoms of the cyclohexane rings, e.g. kanamycins, tobramycin, nebramycin, gentamicin A2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/08—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D263/16—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D263/18—Oxygen atoms
    • C07D263/20—Oxygen atoms attached in position 2
    • C07D263/24—Oxygen atoms attached in position 2 with hydrocarbon radicals, substituted by oxygen atoms, attached to other ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D265/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D265/04—1,3-Oxazines; Hydrogenated 1,3-oxazines
    • C07D265/06—1,3-Oxazines; Hydrogenated 1,3-oxazines not condensed with other rings
    • C07D265/08—1,3-Oxazines; Hydrogenated 1,3-oxazines not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D265/10—1,3-Oxazines; Hydrogenated 1,3-oxazines not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with oxygen atoms directly attached to ring carbon atoms
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Communicable Diseases (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
PL1977202443A 1976-02-25 1977-02-25 A process of producing new cyclic urethans PL102193B1 (pl)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB7529/76A GB1529243A (en) 1976-02-25 1976-02-25 Process for the preparation of aminoglycoside derivatives and cyclic urethane intermediates for use therein

Publications (1)

Publication Number Publication Date
PL102193B1 true PL102193B1 (pl) 1979-03-31

Family

ID=9834870

Family Applications (2)

Application Number Title Priority Date Filing Date
PL1977202443A PL102193B1 (pl) 1976-02-25 1977-02-25 A process of producing new cyclic urethans
PL1977196266A PL103737B1 (pl) 1976-02-25 1977-02-25 Sposob wytwarzania 1-n-aminoglikozydow

Family Applications After (1)

Application Number Title Priority Date Filing Date
PL1977196266A PL103737B1 (pl) 1976-02-25 1977-02-25 Sposob wytwarzania 1-n-aminoglikozydow

Country Status (26)

Country Link
US (1) US4107435A (2)
JP (1) JPS52111545A (2)
AR (1) AR215616A1 (2)
AT (1) AT348123B (2)
BE (1) BE851777A (2)
CA (1) CA1071624A (2)
CH (1) CH618706A5 (2)
CS (2) CS195715B2 (2)
DD (2) DD135200A5 (2)
DE (1) DE2708008C3 (2)
DK (1) DK82177A (2)
EG (1) EG12650A (2)
ES (1) ES456304A1 (2)
FI (1) FI770568A7 (2)
FR (2) FR2351109A1 (2)
GB (1) GB1529243A (2)
GR (1) GR66424B (2)
HU (1) HU179565B (2)
IE (1) IE44885B1 (2)
LU (1) LU76829A1 (2)
NL (2) NL166265C (2)
PL (2) PL102193B1 (2)
PT (1) PT66229B (2)
RO (1) RO76081A (2)
SE (1) SE7702066L (2)
SU (1) SU659092A3 (2)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5461151A (en) * 1977-10-25 1979-05-17 Shionogi & Co Ltd Novel aminoglycoside derivative
US4327087A (en) * 1978-01-16 1982-04-27 Schering Corporation Stabilized Netilmicin formulations
US4223022A (en) * 1978-01-16 1980-09-16 Schering Corporation Stabilized aminoglycoside antibiotic formulations
JPS5538345A (en) * 1978-09-11 1980-03-17 Shionogi & Co Ltd Novel aminoglycoside derivative
US4226980A (en) * 1978-12-07 1980-10-07 Abbott Laboratories Novel derivatives of fortimicin B and process for preparing same
DE2924659A1 (de) * 1979-06-19 1981-01-22 Bayer Ag Pseudotrisaccharide, ihre herstellung und verwendung als arzneimittel
DE3000841A1 (de) * 1980-01-11 1981-07-16 Bayer Ag, 5090 Leverkusen Isolierung und reinigung von aminoglycosid-antibiotiaka
DE3101376A1 (de) * 1981-01-17 1982-09-02 Bayer Ag, 5090 Leverkusen Sisomicin-derivate, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
US4427663A (en) 1982-03-16 1984-01-24 Merck & Co., Inc. 4"-Keto-and 4"-amino-4"-deoxy avermectin compounds and substituted amino derivatives thereof
US7794713B2 (en) 2004-04-07 2010-09-14 Lpath, Inc. Compositions and methods for the treatment and prevention of hyperproliferative diseases
US7862812B2 (en) 2006-05-31 2011-01-04 Lpath, Inc. Methods for decreasing immune response and treating immune conditions
US8314071B2 (en) * 2007-12-21 2012-11-20 Massachusetts Institute Of Technology Bioactive molecules from co-cultivation of microbes
WO2018005964A1 (en) * 2016-07-01 2018-01-04 Wake Forest University Health Sciences Modified carbohydrates, compositions comprising the same, and methods of making and using the same
US10766970B2 (en) 2016-07-01 2020-09-08 Wake Forest University Health Sciences Modified carbohydrates, compositions comprising the same, and methods of making and using the same

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2399118A (en) * 1942-02-13 1946-04-23 Mallinckrodt Chemical Works 2-oxazolidone compounds and method for preparing the same
DE1593321A1 (de) * 1962-04-03 1970-04-02 Rit Rech Ind Therapeut Verfahren zur Herstellung von niederen N-Alkylderivaten basischer Antibiotica

Also Published As

Publication number Publication date
JPS52111545A (en) 1977-09-19
ATA116777A (de) 1978-06-15
GB1529243A (en) 1978-10-18
FR2351109A1 (fr) 1977-12-09
EG12650A (en) 1979-06-30
NL7901693A (nl) 1979-07-31
US4107435A (en) 1978-08-15
CS195715B2 (en) 1980-02-29
DE2708008C3 (de) 1982-04-22
PT66229B (en) 1978-07-17
IE44885L (en) 1977-08-25
FR2351127A1 (fr) 1977-12-09
SE7702066L (sv) 1977-08-26
FI770568A7 (2) 1977-08-26
GR66424B (2) 1981-03-20
DD130150A5 (de) 1978-03-08
AR215616A1 (es) 1979-10-31
HU179565B (en) 1982-11-29
DE2708008A1 (de) 1977-09-01
SU659092A3 (en) 1979-04-25
CS195714B2 (en) 1980-02-29
LU76829A1 (2) 1978-10-18
NL166265B (nl) 1981-02-16
PT66229A (en) 1977-03-01
RO76081A (ro) 1981-08-17
CH618706A5 (2) 1980-08-15
ES456304A1 (es) 1978-01-16
IE44885B1 (en) 1982-05-05
DK82177A (da) 1977-08-26
PL103737B1 (pl) 1979-07-31
NL7701980A (nl) 1977-08-29
CA1071624A (en) 1980-02-12
NL166265C (nl) 1981-07-15
DD135200A5 (de) 1979-04-18
FR2351109B1 (2) 1981-07-24
FR2351127B1 (2) 1981-06-12
DE2708008B2 (de) 1981-07-02
BE851777A (fr) 1977-08-24
AT348123B (de) 1979-01-25

Similar Documents

Publication Publication Date Title
PL102193B1 (pl) A process of producing new cyclic urethans
US5110926A (en) Process for the preparation of a carbocyclic nucleoside analogue
EP0269378A1 (en) Quinazolinone derivative and processes for preparing the same
US5223619A (en) Process for the preparation of 9-substituted guanine derivatives
FI59991B (fi) Foerfarande foer framstaellning av 2-arylamino-2-imidazolin-derivat och deras salter
US4156777A (en) Process for producing glucopyranose-nitrosourea compounds and novel compounds included therein
CA1224460A (en) ANTI-LEUKEMIC .beta.-GLYCOSYL C-NUCLEOSIDES
JPS597718B2 (ja) 新規抗菌剤の中間体
US3976641A (en) Cephalosporin intermediates and process therefor
US4195170A (en) 3',4'-Episulfido kanamycin B compounds
US4904667A (en) 1H-1,2,4-thiadiazolo(3,4-b)quinazolin-5-one-2,2-dioxides, and a method for increasing the cardiac output of a mammal with them
Lohrmann et al. 81. 3-Ribosyluric acid. Part III. Unambiguous syntheses of 3-ribosyluric acid and related compounds
US4357465A (en) 3',4'-Diedeoxykanamycin B derivatives
Urban et al. An Efficient Synthesis Of 6-Substituted 2-(2H-[1, 2, 4] Triazol-3-Ylmethyl)-1, 2, 3, 4-Tetrahydro-Isoquinolines
US3317551A (en) 2-substituted-5-(5-nitro-2-furyl)-1, 3, 4-thiadiazoles
TAKAMIZAWA et al. On the Reaction of Dialkyl Acylphosphonate with 2-Methyl-1, 3, 4-thiadiazolium Salts
KR820000144B1 (ko) 아미노글리코사이드 유도체의 제조방법
KR860000300B1 (ko) 아실우레이도 페니실린 유도체의 제조방법
US667388A (en) Trimethyl-pseudo-uric acid and process of preparing same.
CA1076567A (en) Processes for the preparation of 3',4'-dideoxykanamycin b
PL110862B1 (en) Preparation of novel 6-/d-2-acylamide-2-phenylacetamide/-penicillanic acid
KR860000345B1 (ko) 세팔로스포린 유도체의 제조방법
HU192795B (en) Process for the elimination of 1-sulphonyl group of substituted benzimidazoles
JPS608270A (ja) シクロペンテン環を有する新規ヌクレオシド
JPS59112997A (ja) ２３−置換チオ−２３−デマイシノシル−２３−デオキシデスマイコシン誘導体およびその製法